• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Fuji to market SmartLight units in Japan

Article

Haifa, Israel-based SmartLight announced this month that Fuji Medical Systems will be the exclusive distributor for the company's digital film viewer systems, computer-controlled light boxes that adjust for glare and ambient light when film is mounted

Haifa, Israel-based SmartLight announced this month that Fuji Medical Systems will be the exclusive distributor for the company's digital film viewer systems, computer-controlled light boxes that adjust for glare and ambient light when film is mounted for viewing. The deal represents a major victory for SmartLight, giving the company access to Fuji's strong distribution channels in the lucrative Japanese market.

SmartLight began shipping the systems in February 1997, and has placed more than 200 systems throughout the world. The SmartLight line comprises the SL2000, which has two 14x17-inch viewing fields, the SL4000, with four fields, and the SL8000 and 8000DLX, which use motorized film-transport technology (SCAN 1/21/98).

Price for the viewers ranges from $25,000 to $85,000, substantially more than conventional light boxes, but the company argues that the systems pay for themselves by eliminating the need for two x-ray study retakes per day (SCAN 5/14/97).

Recent Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.